Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: Apalutamide Oral Product; Drug: Androgen Deprivation Therapy (ADT); Procedure: Focal Therapy Sponsors: University of Cincinnati; Janssen, LP Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials